Triptolide inhibits donor-specific antibody production and attenuates mixed antibody-mediated renal allograft injury
Daqiang Zhao(Sun Yat-sen University), Qiquan Sun(Nanjing University of Science and Technology), Zihuan Luo(Sun Yat-sen University), Mingyu Liu(General Hospital of Guangzhou Military Command), Xiaonan Liu(Shanghai Jiao Tong University), Siwen Li(Capital Medical University), Wei Yuan(Shanghai Public Health Clinical Center), Tao Liao(Tsinghua University), Fei Han(Hangzhou Center for Disease Control and Prevention)
Cited by 27
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2019|649
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
|Cell Death and Disease|2016|574
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
|European Urology|2019|464